The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Intelligent Bio Solutions Non Current Liabilities Total account and
Common Stock. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Intelligent Bio's Non Current Liabilities Total and Common Stock is 0.51. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock in the same time period over historical financial statements of Intelligent Bio Solutions, assuming nothing else is changed. The correlation between historical values of Intelligent Bio's Non Current Liabilities Total and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Intelligent Bio Solutions are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Non Current Liabilities Total i.e., Intelligent Bio's Non Current Liabilities Total and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.51 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Most indicators from Intelligent Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
At this time, Intelligent Bio's
Enterprise Value Over EBITDA is comparatively stable compared to the past year.
Enterprise Value Multiple is likely to gain to 0.30 in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.9
M in 2024.
When running Intelligent Bio's price analysis, check to
measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to
predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.